Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07384910
NA

Assessment of GARP Expression in Acute and Chronic Coronary Syndrome

Sponsor: Université Catholique de Louvain

View on ClinicalTrials.gov

Summary

The leading cause of death is cardiovascular diseases in occidental countries. Of those, atherosclerosis is the major contributor to this burden being notably responsible for strokes and myocardial infarctions. The genesis of atherosclerosis is linked to both lipid accumulation and inflammation in the vascular wall of major arteries. One of the major pathways of inflammation is the TGF-beta axis which is at least partially regulated by the GARP protein. It has been investigated mostly in cancer biology but data in cardiovascular disease is lacking. Thus, the investigators aim to characterize the contribution of this protein by investigating its expression in circulating blood cells from patients with an acute or chronic coronary syndrom. The main cells expressing the GARP protein are the platelets and the T regulating cells which will be the main focus.

Official title: Assessment of GARP Expression and Inflammatory Cytokines in Acute and Chronic Coronary Syndrome

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

600

Start Date

2026-02

Completion Date

2028-01

Last Updated

2026-02-17

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

Arterial blood sample

An arterial blood sample will be obtained at the beginning of the coronary angiography by using the arterial sheat in place.

Locations (1)

Cliniques Universitaires Saint-Luc

Brussels, Belgium